Media

Vicore Pharma Completes Enrollment in the Phase 2b ASPIRE Trial of Buloxibutid in Idiopathic Pulmonary Fibrosis

Aprea Therapeutics to Provide Clinical Update on ACESOT-1051 Phase 1 Trial Evaluating WEE1 Inhibitor, APR-1051, at ASCO 2026 Annual Meeting

Adcendo ApS Provides Updates on Pipeline Progress and Recent Achievements for Its First- and Best-in-Class Antibody-Drug Conjugates

Spruce Biosciences Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants

Intervacc – Unprecedented decision opens the way for the launch of Strangvac in Iceland

Oncopeptides – Annual General Meeting in Oncopeptides

Kivu Bioscience to Present Preclinical Data on Next-Generation ADC Programs at AACR Annual Meeting 2026

Kivu Bioscience Appoints Mohit Trikha, Ph.D., as Chief Executive Officer

Adcendo ApS Completes $75 Million Series C Financing to Continue Advancing First- and Best-in-class Clinical ADC Pipeline

Intervacc publishes the 2025 Annual Report